Added to YB: 2026-10-09
Pitch date: 2026-10-06
CLN.SW [neutral]
Clariant AG
+0.47%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific.
Market Cap
CHF 3.5B
Pitch Price
CHF 10.60
Price Target
N/A
Dividend
3.95%
EV/EBITDA
7.83
P/E
-106.27
EV/Sales
1.36
Sector
Chemicals
Category
turnaround
Clariant (CLN Switzerland): Catalysts approach a recovery
CLN.SW (update): Clariant’s Catalysts business could rebound after Q2 volumes fell 14.2%, with postponed replacements potentially contributing from Q4 and becoming more meaningful in 2027, supplemented by Chinese PDH new-build demand. Additives and adsorbents provide steadier support, while the Shell claim dismissal and CHF176m R. Stahl proceeds ease the legal overhang and strengthen the balance sheet. Timing remains uncertain amid depressed Asian and Middle Eastern petrochemical utilisation and additional litigation.
Read full article (2 min)